drugset
drugset / Trial / NCT00225511

Study Evaluating Effexor XR for Major Depression.

NCT00225511 ↗

Phase 3 Completed 590 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
Non-randomizedParallel-groupDouble-blindTreatment

Summary

Study Evaluating Effexor XR for Major Depression.

Timeline

Start
2004-06
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Effexor XR Unknown — —
Subject Milnacipran Other / unclassified — —

Indications

depressive disorder